Granulomatosis after autologous stem cell transplantation in nonHodgkin lymphoma – experience of single institution and a review of literature
References
- Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis.
Lancet 2014;383 : 1155-67. - Ulaner GA, Lilienstein J, Gönen M, Maragulia J, Moskowitz CH, Zelenetz AD. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
J Clin Oncol 2014;32 : 51-6. - Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the international conference on malignant lymphomas imaging working group.
J Clin Oncol 2014;32 : 3048-58. - Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, et al. Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.
Radiol Oncol 2013;47 : 103-10. - Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin’s lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
J Clin Oncol 2001;19 : 414-9. - Spagnolo P, Luppi F, Roversi P, Cerri S, Fabbri LM, Richeldi L. Sarcoidosis: challenging diagnostic aspects of an old disease.
Am J Med 2012;125 : 118-25. - Brady B, Kamel D, Kiely J, Hennessy B. Dual diagnosis of sarcoidosis and lymphoma.
Ir J Med Sci 2013;182 : 283-6. - Han HS, Escalón MP, Hsiao B, Serafini A, Lossos IS. High incidence of falsepositive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens.
Ann Oncol 2009;20 : 309-18. - Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Wholebody positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
Blood 1999;94 : 429-33. - Naumann R, Vaic A, Beuthien-Baumann B, Bredow J, Kropp J, Kittner T, et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma.
Br J Haematol 2001;115 : 793-800. - Gawande RS, Khurana A, Messing S, Zhang D, Castaneda RT, Goldsby RE, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT.
Radiology 2012;262 : 613-22. - Suen JS, Forse MS, Hyland RH, Chan CK. The malignancy-sarcoidosis syndrome.
Chest 1990;98 : 1300-2. - Kornacker M, Kraemer A, Leo E, Ho AD. Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin’s lymphoma: report of two cases.
Ann Hematol 2002;81 : 103-5. - Fishman JA. Approach to the immunocompromised patient with fever and pulmonary infiltrates. In: Marr KA, Thorner AR, editors.
Uptodate.com . UpToDate; C 2013 [citated 2014 Oct 19]. Available from:http://www.uptodate.com/ - Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis.
Br J Cancer 1974;29 : 24-52. - Brincker H. The sarcoidosis-lymphoma-syndrome.
Br J Cancer 1986;54 : 467-73. - Inoue K, Goto R, Shimomura H, Fukuda H. FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment.
Springerplus 2013;2 : 113. - Cohen PR, Kurzrock R. Sarcoidosis and malignancy.
Clin Dermatol 2007;25 : 326-33. - Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
Clin Radiol 2009;64 : 675-81. - Hunsaker AR, Munden RF, Pugatch RD, Mentzer SJ. Sarcoidlike reaction in patients with malignancy.
Radiology 1996;200 : 255-61. - Hunt BM, Vallières E, Buduhan G, Aye R, Louie B. Sarcoidosis as a benign cause of lymphadenopathy in cancer patients.
Am J Surg 2009;197 : 629-32. - Brincker H. Sarcoid reactions in malignant tumours.
Cancer Treat Rev 1986;13 : 147-56. - Haran MZ, Feldberg E, Berrebi A. Lymphoma masking sarcoidosis.
Leuk Lymphoma 2002;43 : 1709-10. - Merchant TE, Filippa DA, Yahalom J. Sarcoidosis following chemotherapy for Hodgkin’s disease.
Leuk Lymphoma 1994;13 : 339-47. - Kim MH, Lee K, Kim KU, Park HK, Lee MK, Suh DS. Sarcoidosis mimicking cancer metastasis following chemotherapy for ovarian cancer.
Cancer Res Treat 2013;45 : 354-8. - Torchio M, Bottaro G, Bertolino G, Comolli G, Bello BD, Invernizzi R, et al. Late-onset sarcoidosis in a patient with gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma: A case report.
Oncol Lett 2014;8 : 1299-301.
Language: English
Page range: 355 - 359
Submitted on: May 21, 2015
Accepted on: Jun 30, 2015
Published on: Nov 9, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2016 Lucka Boltezar, Ivana Zagar, Barbara Jezersek Novakovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.